First Trust Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-802,119
Closed -$81.5M 2649
2025
Q4
$81.5M Sell
802,119
-172,327
-18% -$13.8M 0.06% 397
2025
Q3
$53.3M Buy
974,446
+244,516
+33% +$12.2M 0.04% 536
2025
Q2
$38.8M Sell
729,930
-18,983
-3% -$964K 0.03% 671
2025
Q1
$32.4M Sell
748,913
-53,854
-7% -$2.73M 0.03% 706
2024
Q4
$45.1M Sell
802,767
-24,854
-3% -$1.55M 0.04% 567
2024
Q3
$56.4M Buy
827,621
+318,710
+63% +$18M 0.05% 462
2024
Q2
$21.5M Sell
508,911
-342,045
-40% -$18.8M 0.02% 765
2024
Q1
$58.8M Sell
850,956
-41,668
-5% -$2.64M 0.06% 430
2023
Q4
$66M Sell
892,624
-36,580
-4% -$2.4M 0.07% 368
2023
Q3
$63.4M Sell
929,204
-351,592
-27% -$29.8M 0.08% 366
2023
Q2
$120M Sell
1,280,796
-52,008
-4% -$4.06M 0.14% 181
2023
Q1
$90.4M Sell
1,332,804
-8,825
-0.7% -$567K 0.1% 261
2022
Q4
$66.4M Buy
1,341,629
+395,660
+42% +$16.2M 0.08% 386
2022
Q3
$30.7M Buy
945,969
+251,091
+36% +$10.4M 0.04% 548
2022
Q2
$27.4M Sell
694,878
-5,664
-0.8% -$303K 0.03% 597
2022
Q1
$49M Buy
700,542
+99,441
+17% +$7.27M 0.05% 509
2021
Q4
$46.8M Buy
601,101
+34,504
+6% +$3.05M 0.05% 520
2021
Q3
$54.1M Sell
566,597
-210,861
-27% -$22.3M 0.06% 442
2021
Q2
$96.6M Sell
777,458
-68,769
-8% -$8.21M 0.1% 245
2021
Q1
$112M Sell
846,227
-197,111
-19% -$27M 0.14% 188
2020
Q4
$138M Buy
1,043,338
+114,087
+12% +$13.8M 0.18% 138
2020
Q3
$94.7M Buy
929,251
+51,629
+6% +$4.46M 0.15% 159
2020
Q2
$76.3M Buy
877,622
+123,600
+16% +$9.88M 0.13% 190
2020
Q1
$43.7M Buy
754,022
+179,725
+31% +$14.6M 0.1% 324
2019
Q4
$53.1M Sell
574,297
-307,761
-35% -$27.1M 0.09% 326
2019
Q3
$79.7M Sell
882,058
-653,722
-43% -$74.5M 0.15% 165
2019
Q2
$181M Buy
1,535,780
+1,057,434
+221% +$107M 0.34% 40
2019
Q1
$41.4M Sell
478,346
-290,299
-38% -$24.7M 0.08% 310
2018
Q4
$48.5M Buy
768,645
+243,901
+46% +$16.7M 0.12% 217
2018
Q3
$41.4M Buy
524,744
+516,442
+6,221% +$33.7M 0.08% 301
2018
Q2
$496K Sell
8,302
-73,225
-90% -$3.94M ﹤0.01% 2156
2018
Q1
$3.29M Buy
81,527
+3,199
+4% +$156K 0.01% 1187
2017
Q4
$4.12M Buy
78,328
+9,630
+14% +$514K 0.01% 1092
2017
Q3
$3.24M Sell
68,698
-33,959
-33% -$1.37M 0.01% 1196
2017
Q2
$3.63M Buy
102,657
+54,121
+112% +$1.67M 0.01% 1146
2017
Q1
$1.15M Sell
48,536
-45,545
-48% -$903K ﹤0.01% 1807
2016
Q4
$1.26M Buy
+94,081
New +$1.52M ﹤0.01% 1723
2015
Q4
Sell
-4,669,070
Closed -$84M 2258
2015
Q3
$84M Sell
4,669,070
-195,494
-4% -$4.49M 0.24% 87
2015
Q2
$145M Buy
4,864,564
+1,380,913
+40% +$34.7M 0.38% 39
2015
Q1
$76.7M Buy
3,483,651
+868,313
+33% +$22M 0.23% 93
2014
Q4
$71.8M Sell
2,615,338
-1,568,180
-37% -$38.2M 0.24% 80
2014
Q3
$81.1M Sell
4,183,518
-307,786
-7% -$5.64M 0.32% 44
2014
Q2
$76.5M Buy
4,491,304
+428,795
+11% +$5.9M 0.32% 37
2014
Q1
$57.6M Buy
4,062,509
+138,092
+4% +$1.86M 0.25% 52
2013
Q4
$46.1M Buy
3,924,417
+1,142,842
+41% +$13.1M 0.22% 73
2013
Q3
$32.8M Buy
+2,781,575
New +$35.7M 0.18% 117

Other funds holding EXAS

First Trust Advisors's EXAS Position: Q1 2026 in Review

First Trust Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 802,119 shares — an estimated $81.5M sold.

First Trust Advisors first reported a position in EXAS in Q3 2013 and held it in 46 quarters. The position peaked at $181M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • First Trust Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • First Trust Advisors sold 802,119 Exact Sciences shares in Q1 2026, an estimated $81.5M.
  • First Trust Advisors first reported a position in Exact Sciences in Q3 2013 and held it in 46 quarters.
  • First Trust Advisors's Exact Sciences position peaked at $181M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.